A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea. / Gottlieb, Lisa A.
In: Journal of Cardiovascular Pharmacology, 2024.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Gottlieb, LA 2024, 'A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea', Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/FJC.0000000000001527
APA
Gottlieb, L. A. (2024). A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/FJC.0000000000001527
Vancouver
Gottlieb LA. A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea. Journal of Cardiovascular Pharmacology. 2024. https://doi.org/10.1097/FJC.0000000000001527
Author
Bibtex
@article{f30050a95ba0443982131b461aaca88d,
title = "A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea",
author = "Gottlieb, {Lisa A}",
year = "2024",
doi = "10.1097/FJC.0000000000001527",
language = "English",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams & Wilkins",
}
RIS
TY - JOUR
T1 - A potential role for pharmacological phosphodiesterase 5 inhibitors in the treatment of obstructive sleep apnea
AU - Gottlieb, Lisa A
PY - 2024
Y1 - 2024
U2 - 10.1097/FJC.0000000000001527
DO - 10.1097/FJC.0000000000001527
M3 - Journal article
C2 - 38086080
JO - Journal of Cardiovascular Pharmacology
JF - Journal of Cardiovascular Pharmacology
SN - 0160-2446
ER -
ID: 396849518